More on HMA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.0 Score)
- Holders

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

HMA Cash Flow Statement

Click line-items for a historical chart and %
Consolidated net income -40.18M
Depreciation and amortization 298.54M
Provision for doubtful accounts 729.7M
Stock-based compensation expense 58.85M
Losses (gains) on sales of assets, net -1.14M
Gains on sales of available-for-sale securities, net -1.48M
Deferred income tax expense (benefit) 45.11M
Accounts receivable -784.62M
Supplies, prepaid expenses and other current assets -100.4M
Prepaid and recoverable income taxes
Deferred charges and other long-term assets -5.19M
Accounts payable
Accrued expenses and other liabilities -116.33M
Equity compensation excess income tax benefits -19.06M
Loss from discontinued operations, net 0
Net cash provided by continuing operating activities 120.21M
Additions to property, plant and equipment -207.65M
Acquisitions, including ancillary health care businesses -173.65M
Proceeds from sales of assets and insurance recoveries
Purchases of available-for-sale securities -471.92M
Proceeds from sales of available-for-sale securities 530.2M
Increase in restricted funds
Net cash used in continuing investing activities -317.72M
Principal payments on debt and capital lease obligations -358.51M
Proceeds from exercises of stock options 27.95M
Cash received from noncontrolling shareholders 0
Cash payments to noncontrolling shareholders -24.18M
Equity compensation excess income tax benefits 19.06M
Net cash used in continuing financing activities 139.63M
Net increase (decrease) in cash and cash equivalents before discontinued operations -57.88M
Operating activities 0
Investing activities 0
Net increase (decrease) in cash and cash equivalents -57.88M
Cash and cash equivalents at the beginning of the period 59.17M
Cash and cash equivalents at the end of the period 1.29M